Cargando…
Delayed-release oral mesalamine tablet mimicking a small jejunal gastrointestinal stromal tumor: A case report
BACKGROUND: Enteric-coated medications are supposed to pass intact through the gastric environment and to release the drug content into the small intestine or the colon. Before dissolution of the enteric coating, they may appear hyperdense on computed tomography (CT). Unfortunately, few reports have...
Autores principales: | Frosio, Fabio, Rausa, Emanuele, Marra, Paolo, Boutron-Ruault, Marie-Christine, Lucianetti, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294894/ https://www.ncbi.nlm.nih.gov/pubmed/35979321 http://dx.doi.org/10.12998/wjcc.v10.i19.6710 |
Ejemplares similares
-
Gastric Pharmacobezoar of Mesalamine Tablets Retrieved Endoscopically
por: Sultania, Surender, et al.
Publicado: (2017) -
Bioavailability and swallowability of an age-appropriate, delayed-release mesalamine formulation in healthy volunteers
por: Jakate, Abhijeet, et al.
Publicado: (2019) -
Football Size Jejunal Gastrointestinal Stromal Tumour
por: Monib, Sherif, et al.
Publicado: (2020) -
Development and Validation of Spectrophotometric Methods for the Estimation of Mesalamine in Tablet Dosage Forms
por: Patel, KM, et al.
Publicado: (2010) -
Jejunal Gastrointestinal Stromal Tumor: A Diagnostic Challenge
por: Miranda, Edison D, et al.
Publicado: (2023)